We aimed to investigate serum adiponectin and PPAR-γ levels of both prediabetic obeseand non-prediabetic obese patients in the design of our study as obesity is known tobe a risk factor for the development of T2DM and prediabetes is a risk factor forthe development of T2DM. The gene discussed is ADIPOQ; the disease is Obesity.